-
Something wrong with this record ?
Nodular type but not vitamin D levels increases the risk of second primary cancers in melanoma patients: An observational study of 663 patients
A. Massa, A. Isasi-Fuster, C. Requena, E. Manrique-Silva, R. Kumar, E. Nagore
Language xxx, English Country Spain
Document type Observational Study, Journal Article
NLK
Directory of Open Access Journals
from 2020
ROAD: Directory of Open Access Scholarly Resources
from 1996
- MeSH
- Middle Aged MeSH
- Humans MeSH
- Melanoma * epidemiology etiology diagnosis MeSH
- Skin Neoplasms * etiology complications MeSH
- Vitamin D Deficiency * complications epidemiology MeSH
- Retrospective Studies MeSH
- Neoplasms, Second Primary * epidemiology etiology MeSH
- Vitamin D adverse effects MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Observational Study MeSH
BACKGROUND: Vitamin D deficiency associates with the risk of developing many diseases, including cancer. At the molecular level, vitamin D appears to have an antineoplastic effect. However, the role of vitamin D deficiency in cancer pathogenesis remains unelucidated and numerous studies have resulted in discordant results. This study aimed to determine whether vitamin D deficiency during melanoma diagnosis increases the risk of developing non-cutaneous second primary cancers (SPC). MATERIALS AND METHODS: A retrospective study on 663 patients diagnosed with melanoma between 1 January 2011 and 31 October 2022. The effect of each variable on the development of a subsequent non-cutaneous cancer was performed using Kaplan-Meier curves and differences were assessed by log-rank tests. Cox proportional hazard univariate and multivariate models were used to quantify the effect of each variable in the time to develop a non-cutaneous neoplasia. RESULTS: Out of 663 patients, 34 developed a non-cutaneous SPC. There was no statistically significant association between vitamin D levels and non-cutaneous SPC development (log-rank, p=0.761). Age>60 years, stage III/IV, and nodular melanoma subtype were significantly associated with the development of a SPC. After multivariate analysis, only age>60 years (HR 3.4; HR CI 95%: 1.5-7.6) and nodular melanoma subtype (HR 2.2; HR CI 95%: 1.0-4.8) were included in the final model. CONCLUSIONS: Our results suggest that vitamin D deficiency is not associated with an increased risk of developing non-cutaneous SPC in melanoma patients. However, age over 60 years and nodular melanoma subtype increase the risk for non-cutaneous SPC development.
Department of Dermatology Fundación Instituto Valenciano de Oncología València Spain
Institute of Experimental Medicine Czech Academy of Sciences Prague Czech Republic
Institute of Medical Biometry University of Heidelberg Heidelberg Germany
School of Medicine Universidad Católica de Valencia San Vicente Mártir València Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007435
- 003
- CZ-PrNML
- 005
- 20240423155945.0
- 007
- ta
- 008
- 240412s2024 sp f 000 0|eng s
- 009
- AR
- 024 7_
- $a 10.1016/j.ad.2023.10.001 $2 doi
- 035 __
- $a (PubMed)37832865
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng spa
- 044 __
- $a sp
- 100 1_
- $a Massa, A $u Section of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
- 245 10
- $a Nodular type but not vitamin D levels increases the risk of second primary cancers in melanoma patients: An observational study of 663 patients / $c A. Massa, A. Isasi-Fuster, C. Requena, E. Manrique-Silva, R. Kumar, E. Nagore
- 520 9_
- $a BACKGROUND: Vitamin D deficiency associates with the risk of developing many diseases, including cancer. At the molecular level, vitamin D appears to have an antineoplastic effect. However, the role of vitamin D deficiency in cancer pathogenesis remains unelucidated and numerous studies have resulted in discordant results. This study aimed to determine whether vitamin D deficiency during melanoma diagnosis increases the risk of developing non-cutaneous second primary cancers (SPC). MATERIALS AND METHODS: A retrospective study on 663 patients diagnosed with melanoma between 1 January 2011 and 31 October 2022. The effect of each variable on the development of a subsequent non-cutaneous cancer was performed using Kaplan-Meier curves and differences were assessed by log-rank tests. Cox proportional hazard univariate and multivariate models were used to quantify the effect of each variable in the time to develop a non-cutaneous neoplasia. RESULTS: Out of 663 patients, 34 developed a non-cutaneous SPC. There was no statistically significant association between vitamin D levels and non-cutaneous SPC development (log-rank, p=0.761). Age>60 years, stage III/IV, and nodular melanoma subtype were significantly associated with the development of a SPC. After multivariate analysis, only age>60 years (HR 3.4; HR CI 95%: 1.5-7.6) and nodular melanoma subtype (HR 2.2; HR CI 95%: 1.0-4.8) were included in the final model. CONCLUSIONS: Our results suggest that vitamin D deficiency is not associated with an increased risk of developing non-cutaneous SPC in melanoma patients. However, age over 60 years and nodular melanoma subtype increase the risk for non-cutaneous SPC development.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a melanom $x epidemiologie $x etiologie $x diagnóza $7 D008545
- 650 _2
- $a vitamin D $x škodlivé účinky $7 D014807
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a sekundární malignity $x epidemiologie $x etiologie $7 D016609
- 650 12
- $a nádory kůže $x etiologie $x komplikace $7 D012878
- 650 12
- $a nedostatek vitaminu D $x komplikace $x epidemiologie $7 D014808
- 655 _2
- $a pozorovací studie $7 D064888
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Isasi-Fuster, A $u School of Medicine, Universidad Católica de Valencia San Vicente Mártir, València, Spain
- 700 1_
- $a Requena, C $u Department of Dermatology, Fundación Instituto Valenciano de Oncología, València, Spain
- 700 1_
- $a Manrique-Silva, E $u Department of Dermatology, Fundación Instituto Valenciano de Oncología, València, Spain
- 700 1_
- $a Kumar, R $u Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany; Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Nagore, E $u School of Medicine, Universidad Católica de Valencia San Vicente Mártir, València, Spain; Department of Dermatology, Fundación Instituto Valenciano de Oncología, València, Spain. Electronic address: eduardo.nagore@ucv.es
- 773 0_
- $w MED00000151 $t Actas dermo-sifiliográficas $x 1578-2190 $g Roč. 115, č. 2 (2024), s. 143-149
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37832865 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155941 $b ABA008
- 999 __
- $a ok $b bmc $g 2081426 $s 1217202
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 115 $c 2 $d 143-149 $e 20231011 $i 1578-2190 $m Actas dermo-sifiliográficas $n Actas Dermosifiliogr $x MED00000151
- LZP __
- $a Pubmed-20240412
